Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics

<b>Background</b>: Mitoxantrone (MX) is regularly used to treat several cancers. Despite its long history in the clinic, recent studies continue to unveil novel protein targets. These targets may contribute to the cytotoxic effects of the drug, as well as potential non-canonical antitumor activity....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Savanna Wallin, Sneha Pandithar, Sarbjit Singh, Siddhartha Kumar, Amarnath Natarajan, Gloria E. O. Borgstahl, Nicholas Woods
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-11-01
Colecção:	Proteomes
Assuntos:	mitoxantrone homologous recombination-deficiency ovarian cancer BRCA1 DNA repair proteomics
Acesso em linha:	https://www.mdpi.com/2227-7382/13/4/61
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!